Peter I. Tattersall

Rational design of bleachable nonchemically amplified DUV photoactive compounds

C. Grant Willson, Cyrus E. Tabery, David R. Medeiros, 2001, SPIE Advanced Lithography.

Leveraging AQbD Principles for Development of Challenging Drug Substance Stability-Indicating Methods

Peter I. Tattersall, Jieming Li, Elizabeth M. Yuill, 2021 .

Synthesis and Properties of Diazopiperidiones for Use in Nonchemically Amplified Deep UV Photoresists

Christopher L. McAdams, William H. Heath, Peter I. Tattersall, 2004 .

Development of Stability Indicating Methods

Peter I. Tattersall, A. Aubry, J. Ruan, 2009 .

Rapid development of a bromochloropyridine regioisomer purity method enabled by strategic LC screening.

Peter I. Tattersall, Amaris C. Borges-Muñoz, Li Li, 2020, Journal of pharmaceutical and biomedical analysis.

Synthesis of a phosphinic acid analogue of cyclic AMP

Peter I. Tattersall, A. Regan, N. Sciammetta, 2000 .

Derivatization and determination of residual N,N-Carbonyldiimidazole by LC for an in-process control test.

Peter I. Tattersall, Amaris C. Borges-Muñoz, H. Patel, 2021, Journal of pharmaceutical and biomedical analysis.

Development of a Reversed-Phase HPLC Impurity Method for a UV Variable Isomeric Mixture of a CRF Drug Substance Intermediate with the Assistance of Corona CAD

Peter I. Tattersall, Zongyun Huang, R. Lozano, 2011, Journal of Pharmaceutical Innovation.